Search Results - Paul C. H. Lee
- Showing 1 - 1 results of 1
-
1
Safety, tolerability, pharmacokinetics, and pharmacodynamics of HBM9161, a novel FcRn inhibitor, in a phase I study for healthy Chinese volunteers by Desmond Y. H. Yap, Jojo Hai, Paul C. H. Lee, Xueying Zhou, Michael Lee, Yu Zhang, Meng Wang, Xiaoxiang Chen
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book